The Brexit effect: What is happening to the UK science industry?

It’s still impossible to know the full effect of the Brexit referendum on the UK science industry. The vote to leave the European Union...

Manisha Raja, Dermatology Account Manager at LEO Pharma and winner of the Secondary Care...

Congratulations on your Pf Award win Manisha, how did it feel when your name was announced? Thank you! My jaw dropped when my name was...

BD and iTS Leadership demonstrate how honesty and an appetite to solve problems can...

  Tracey Clarke HR Director for UK/Ireland and the Nordic region, BD, on how to create a no-blame culture of continuous learning.   What is BD? BD is a...

Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who...

Novel gene therapy shows promise Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who suffer from an incurable skin...

Consilient Health’s Ian Sampson on the importance of traditional sales skills in an evolving...

  More than ever, we are adopting new and innovative ways to communicate, and pharma is no different. Whilst traditional sales skills are just as...

eDetailing: Where are we in 2018?

Words by Dr Andrée Bates Detailing remains a core part of any pharmaceutical company’s sales approach and has become a large part of their promotional...

How can pharma harness the power of data to inform its scientific communications strategy?

Words by Simon Mason Navigating the fast-changing healthcare data landscape is becoming increasingly challenging for pharma, owing to issues such as the rapid growth of...

Foreseeable future: MSD’s focus on emerging talent

    Adelina Ismail Role: Graduate Brand and Customer Manager, Vaccines & Women’s Health Degree: BSc Marketing Management (Hons), Lancaster University 2-year graduate scheme: First year as a junior brand...

Gaining access: For products to commercially succeed it’s about what and who you know

Words by Andreas Knight   Many consider market access as a new component of commercial pharma, but in reality it has always been around in one...

Latest articles

Image of a man pumping air into a pund symbol to indicate drug firms admitting to colluding to keep up prices of antidepressants

Drug firms admit to colluding to keep up prices of antidepressants

Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
Licensing status of Avastin updated by MHRA

Licensing status of Avastin updated by MHRA

The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners

PM Society Digital Award Winners 2019

Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Licensing status of Avastin updated by MHRA

Licensing status of Avastin updated by MHRA

The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners

PM Society Digital Award Winners 2019

Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
image of a hospital and ambulance showing poor diabetes control costs the NHS £3bn in avoidable treatment

Poor diabetes control costs the NHS £3bn in avoidable treatment

New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Image of a man pumping air into a pund symbol to indicate drug firms admitting to colluding to keep up prices of antidepressants

Drug firms admit to colluding to keep up prices of antidepressants

Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription